GENO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Genovis delivers biotechnology tools and technology platforms to the life sciences and pharmaceutical industries. The company develops enzyme and inhibitor technologies that facilitate, or are integral parts of, a wide range of processes from basic research to pharmaceutical manufacturing and diagnostics. The company operates on a global scale, with customers primarily in North America, Europe and East Asia. Genovis was founded in 1999 and is headquartered in Kävlinge.
Read moreRevenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Interim report Q2'26
Interim report Q3'26
Don't miss out - create an account and get all the possible benefits